In breast cancer progression, Ras/Raf/MEK/MAPK and PI3K/Akt/mTOR signaling pathways are commonly dysregulated by the crosstalk among various growth factors and hormone receptors including HER2 and ER [13]. The gene discussed is NR4A1; the disease is breast carcinoma.